Celgene Corporation - CELG (NASDAQ-GS)

88.30
0.00 (0.00%)
Quotes delayed 15 mins. Currently September 21, 2018 9:30:16 AM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Celgene develops and markets therapeutics to treat cancer and immune-inflammatory related diseases

Key Financials

Day Range:87.00 - 88.41
52 Week Range:74.13 - 147.17
Open:--
Shares:703.36M
Market Cap:62.11B
EPS:3.66
P/E Ratio:24.10
Div Yield:--
Performance
Previous close
No Chart Available
Purchase CELG in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of CELG not only as a single stock, but also as part of a motif.
Professional Motifs with CELG
Battling Cancer
Battling Cancer 15.0% 1 YR RTN New drugs and devices could be a game-changer for the war on the nation's second-biggest killer.
Biotech Breakthroughs
Biotech Breakthroughs 0.9% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with CELG
Community Motifs with CELG
Value for Money
Value for Money 16.9% 1 YR RTN
Spare change only
Spare change only 14.2% 1 YR RTN
View all community motifs with CELG
What Others Think About CELG
theo
.@AndreaPMalizia $XLRN $CELG $XBI $IBB $BLUE wanted to repost this as $XLRN is hitting ALL TIME HIGHS.
Michael B. Kuritz
RT @odibro : $OMED .. $CELG will not exercise option to license OncoMed's navicixizumab globenewswire.com/news-release/2…
5
pivothunter
$CELG breakout of the DTL and nicely bull flagging on the hourly.
Marea Informative
Sio Capital Management LLC Grows Stake in Celgene Co. $CELG mareainformativa.com/?p=1359022
S Manian
RT @DrSManian : $JNCE

Largest stakeholder is Third Rock

Also Chairman of BOD

Impeccable credentials for a management team - ex $MRK $CE…
2
eagle_one
@KpaktradesB $CELG coming out of 30min base
1
Yu Zhu
RT @Biotech2050 : According to my crude calculations (link below):
1. $XLRN fair value is $8.8B vs $2.6B market cap (= $8.8B/ $2.6B x $57 =…
1
Alex Seizew
$OMED $CELG Oncomed has performed terribly, but Celgene has not exactly made the best decisions the last couple of years. Purely speculative, adding here.
Related Companies Within The Biotechnology Sector
Amgen Inc. - 205.10
AMGN
GILD
Biogen Inc. - 341.24
BIIB
Illumina Inc. - 356.32
ILMN
SHPG
Shire plc - 179.98
SHPG